Loading…
State Offices of Women’s Health Support and Expansion Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 10,940 other HR bills in the 119th — cohort avg 30d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (6)
2026 · third_quarter · Health Issues
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Right to Contraception Act (S.422/HR 999) Convenient Contraception Act (H.R. 2529/S. 1239) Expanding Access to Family Planning Act (H.R. 2762/S. 1394) Anti-Racism in Public Health Act (H.R. 2884/S. 1489) Reproductive Data Privacy and Protection Act (H.R. 3218) My Body My Data (H.R. 3916/S. 2029) Real Education and Access for Healthy Youth Act (H.R. 3527/S. 1910) The Health Equity and Access under the Law (HEAL) Act (S. 2149/H.R. 4104) Restoring Essential Healthcare Act (H.R. 4796/S. 2524) Access to Birth Control Act (H.R. 4084/S. 2302) Closing the Contraception Coverage Gap Act (S. 3560) Reproductive Healthcare Accessibility Act (S. 4540/H.R. 8829) SAFER Health Act of 2026 (H.R. 9470/S. 4920) Health Equity and Accountability Act (HEAA) (S. 5066/H.R. 9877) Affordability is Access Act (S. 5539/H.R. 10597) State Offices of Womens Health Support and Expansion Act (H.R. 9842)
Client expense: $18,176 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Health Issues
Advocacy for a bill establishing offices of womens health or supplementing funding if the office is already established. (House) (H.R.9842) Advocacy for Jeanette Acosta Invest in Womens Health Act (S.5546) (Senate) Advocacy for inclusive language in Momnibus (H.R. 7973 and S. 5283) (House & Senate) Advocacy against the nomination of Heidi Overton to be Commissioner of the FDA. (Senate)
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Health Issues
Erica Schwartz, of Florida, to be Director of the Centers for Disease Control and Prevention, vice Susan Monarez. (PN932) Heidi Overton, of New Mexico, to be Commissioner of Food and Drugs, Department of Health and Human Services, vice Martin Makary. (PN1273-17) Rural Obstetrics Readiness Act (S. 380/H.R. 1254) Jeanette Acosta Invest in Womens Health Act of 2026 (S.5546) Chloe Cole Act (H.R. 7651/H.R. 5843) State Offices of Womens Health Support and Expansion Act (H.R. 9842) Access to Claims Data Act (H.R. 4331) Patients First Act of 2026 (H.R. 9693) A Medicaid fix bill (not introduced yet) Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency (SECURE) in 340B Act (H.R. 9599) SUSTAIN 340B Act (S. 5244) Safety Net Provider Drug Pricing Protection Act (not introduced yet) Medicaid streamline enrollment bill (not introduced) Protecting Taxpayers from Health Care Fraudsters Act (H.R. ____) Health Information Privacy Reform Act (S. 3097)
Client expense: $308,925 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Family issues/Abortion/Adoption
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Health Issues
Right to Contraception Act (S.422/HR 999) Convenient Contraception Act (H.R. 2529/S. 1239) Expanding Access to Family Planning Act (H.R. 2762/S. 1394) Anti-Racism in Public Health Act (H.R. 2884/S. 1489) Reproductive Data Privacy and Protection Act (H.R. 3218) My Body My Data (H.R. 3916/S. 2029) Real Education and Access for Healthy Youth Act (H.R. 3527/S. 1910) The Health Equity and Access under the Law (HEAL) Act (S. 2149/H.R. 4104) Restoring Essential Healthcare Act (H.R. 4796/S. 2524) Access to Birth Control Act (H.R. 4084/S. 2302) Closing the Contraception Coverage Gap Act (S. 3560) Reproductive Healthcare Accessibility Act (S. 4540/H.R. 8829) SAFER Health Act of 2026 (H.R. 9470/S. 4920) Health Equity and Accountability Act (HEAA) (S. 5066/H.R. 9877) Affordability is Access Act (S. 5539/H.R. 10597) State Offices of Womens Health Support and Expansion Act (H.R. 9842)
Client expense: $17,436 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Health Issues
Abortion access (general); Access to mifepristone (general); Contraception (general); Maternal mortality and morbidity (general); H.R. 8651/S. _____, Advancing Safe Medications for Moms and Babies Act; Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of labor and delivery units in rural hospitals on patient access to care and maternal morbidity and mortality; abortion training in obstetrics and gynecology residency programs (general); Teaching Health Center Graduate Medication Education program (general); implementation of P.L. 119-21, One Big, Beautiful Bill Act; implementation of Sec. 6501 of P.L. 119-75, Preventing Maternal Deaths Reauthorization Act; Telemedicine (general); S. 380/H.R. 1254, Rural Obstetrics Readiness Act; S. 1834/H.R. 3762, Supporting Healthy Moms and Babies Act; H.R. 7973, Momnibus Act H.R. 9441, SAFE Training for OBGYNs Act; H.R. 9090/S. 4503, Advancing Menopause Care and Mid-Life Womens Health Act; H.R. 10600, Abortion is Health Care Everywhere Act; S. ____, Know Your Risk Act; S. 3254/H.R. 6238, NIH IMPROVE Act; H.R. 9946, Equity in STI Testing Act; H.R. 3387, No Surprise Bills for New Moms Act; H.R. 9842, State Offices of Womens Health Support and Expansion Act; H.R. 2028/S. 942, REDI Act; H.R. 5536, HEADACHE Act; H.Res.739/S.Res.401, National Stillbirth Prevention & Awareness Day Resolution; S. ____, Jeanette Acosta Invest in Womens Health Act; HR.____ /S. 5554, Ovarian Cancer Improving and Modernizing Prevention, Access, Care, and Testing (IMPACT) Act; H.R. ____, Improving Access to WIC Act; H.R. ____/S. ____, Support Through Loss Act; H.R. 6468/S. 5232, Rural Residency Planning and Development Act; H.R. _____/S. 4445, Right to IVF Act; S. 4494, maternal mortality review committees (general); Patient-physician relationship (general); Obstetrician-gynecologist workforce (general); Substance use disorder during pregnancy (general); Maternal mental health (general); Insurance coverage for infertility (general); Protections for in vitro fertilization (general); Vaccination (general); childhood vaccine recommendations (general); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) recommendations (general); inclusion of pregnant and lactating women in clinical trials (general); NIH/NICHD womens health research (general); clinical research workforce development (general); access to fertility services and treatments (general); Advisory Committee on Immunization Practices (ACIP); COVID vaccine during pregnancy (general); United States Preventive Services Taskforce (general); hormone therapy for menopause symptoms (general); Pregnancy Risk Assessment Monitoring System (PRAMS); Maternal Mortality Review Information Application (MMRIA); OMB Regulation for Federal Financial Assistance (OMB-2026-0034-0001); estradiol patch shortage (general); menopause education (general); risk-reducing salpingectomy (general).
2026 · third_quarter · Family issues/Abortion/Adoption
A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; Access to evidence-based medication abortion care; Anti-abortion centers/crisis pregnancy centers; Abortion-coverage restrictions; Reproductive healthcare in FY27 federal spending bills; Access to treatments for infertility/IVF, including; S.5108 and H.R.9941, the Right to IVF Act of 2026; Veterans and their dependants access to reproductive health care; H.R.10597 and S.5539, the Affordability is Access Act of 2026; Healthy pregnancy and post-partum period, including S.4913 and H.R.9816 Maximizing Outcomes for Moms through Medicaid Improvement and Enhancement of Services Act (MOMMIES Act); H.R.9842, State Offices of Womens Health Support and Expansion Act; Family and medical leave, including paid leave; H.Con.Res.56, Recognizing the significance of equal pay and the disparity in wages paid to Latina women in comparison to White, non-Hispanic men; H.Con.Res.114 and S.Con.Res.36, A concurrent resolution recognizing the significance of equal pay and the disparity in wages paid to men and to Black women; Gender equity and sex discrimination; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care; H.R.3838, the FY26 National Defense Authorization Act; Discriminatory hiring practices at DoD.
Client expense: Not reported · Firm income: $10,000
| Democratic |
| CA |
| Yvette D. Clarke | Democratic | NY |
Client expense: $250,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE